HealthcareServices

Induced Pluripotent Stem Cell (iPSC) Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the induced pluripotent stem cell (ipsc) market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Induced Pluripotent Stem Cell (iPSC) Market from 2026 to 2030?

The market for induced pluripotent stem cells (ipsc) has experienced significant expansion in recent years. This market is expected to increase from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth trajectory is primarily driven by advancements in cellular reprogramming research, ethical considerations concerning embryonic stem cells, enhanced funding for stem cell research, an uptick in academic research collaborations, and the rising occurrence of chronic and degenerative diseases.

The induced pluripotent stem cell (ipsc) market is anticipated to experience robust growth in the coming years. It is projected to achieve a size of $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period can be attributed to the broadening of regenerative medicine applications, increasing demand for personalized therapies, rising investment in cell and gene therapy, greater adoption of ipscs in neurological and cardiac research, and favorable regulatory support for advanced therapies. Notable trends expected in this period include the expanding utilization of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the development of more patient-specific cell lines, a growing focus on ethical alternatives to embryonic stem cells, and advancements in reprogramming efficiency and cell stability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

What Drivers Are Affecting Demand In The Induced Pluripotent Stem Cell (iPSC) Market?

The rising incidence of neurological conditions is anticipated to drive expansion in the induced pluripotent stem cell market in the foreseeable future. A neurological disorder is defined as a health ailment impacting the nervous system, which encompasses the brain, spinal cord, and nerves. Frequently encountered neurological disorders include acute spinal cord injury, Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), among others. Pluripotent stem cells present an opportunity for investigating disease mechanisms and performing drug tests, thereby offering understanding into the origins of neurological disorders and assisting in creating regenerative treatments for ailments like Parkinson’s and Alzheimer’s disease. As an illustration, figures from October 2023, released by the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, indicated that over 40% of the world’s population was afflicted by a neurological condition, with the total neurological disease burden forecast to almost double by 2050. Consequently, the growing occurrence of neurological disorders is fueling the expansion of the induced pluripotent stem cell market.

Which Segments Are Gaining Traction In The Induced Pluripotent Stem Cell (iPSC) Market?

The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

What Trends Are Projected To Support The Growth Of The Induced Pluripotent Stem Cell (iPSC) Market?

Leading companies in the Induced Pluripotent Stem Cell (IPSC) market are engaging in collaborations to further develop iPSC Technology, aiming to enhance regenerative medicine applications, refine disease modeling, accelerate drug discovery, and create personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific procedures and methods used to revert adult somatic cells, such as those from skin or blood, back into a pluripotent state, enabling them to differentiate into any cell type within the body. For example, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology company based in Singapore, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, initiated joint laboratories with the objective of advancing cellular immunotherapies. This initiative, supported by close to S$30 million, highlights Singapore’s commitment to progress in biotechnology and healthcare solutions. The collaboration intends to establish scalable manufacturing processes for GMP-grade iPSC products, thereby addressing the challenges of transitioning laboratory innovations into clinically viable therapies.

Who Are The Top-Performing Companies In The Induced Pluripotent Stem Cell (iPSC) Market In Recent Years?

Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

How Does The Induced Pluripotent Stem Cell (iPSC) Market Perform Across Major Global Regions?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Induced Pluripotent Stem Cell (iPSC) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Human Embryonic Stem Cells Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795